share_log

Here's Why Astronics (NASDAQ:ATRO) Can Afford Some Debt

アストロニクス(NASDAQ:ATRO)が多少の借金を負担できる理由

Simply Wall St ·  07/18 07:23

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. We can see that Astronics Corporation (NASDAQ:ATRO) does use debt in its business. But should shareholders be worried about its use of debt?

Why Does Debt Bring Risk?

Debt is a tool to help businesses grow, but if a business is incapable of paying off its lenders, then it exists at their mercy. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

How Much Debt Does Astronics Carry?

The image below, which you can click on for greater detail, shows that Astronics had debt of US$162.1m at the end of March 2024, a reduction from US$172.4m over a year. However, it does have US$5.31m in cash offsetting this, leading to net debt of about US$156.8m.

big
NasdaqGS:ATRO Debt to Equity History July 18th 2024

How Healthy Is Astronics' Balance Sheet?

According to the last reported balance sheet, Astronics had liabilities of US$151.3m due within 12 months, and liabilities of US$227.0m due beyond 12 months. On the other hand, it had cash of US$5.31m and US$170.2m worth of receivables due within a year. So its liabilities total US$202.7m more than the combination of its cash and short-term receivables.

While this might seem like a lot, it is not so bad since Astronics has a market capitalization of US$787.4m, and so it could probably strengthen its balance sheet by raising capital if it needed to. However, it is still worthwhile taking a close look at its ability to pay off debt. The balance sheet is clearly the area to focus on when you are analysing debt. But it is future earnings, more than anything, that will determine Astronics's ability to maintain a healthy balance sheet going forward. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.

In the last year Astronics wasn't profitable at an EBIT level, but managed to grow its revenue by 25%, to US$718m. Shareholders probably have their fingers crossed that it can grow its way to profits.

Caveat Emptor

Even though Astronics managed to grow its top line quite deftly, the cold hard truth is that it is losing money on the EBIT line. To be specific the EBIT loss came in at US$5.4m. When we look at that and recall the liabilities on its balance sheet, relative to cash, it seems unwise to us for the company to have any debt. So we think its balance sheet is a little strained, though not beyond repair. Another cause for caution is that is bled US$10m in negative free cash flow over the last twelve months. So to be blunt we think it is risky. The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately, every company can contain risks that exist outside of the balance sheet. For example, we've discovered 2 warning signs for Astronics (1 can't be ignored!) that you should be aware of before investing here.

If, after all that, you're more interested in a fast growing company with a rock-solid balance sheet, then check out our list of net cash growth stocks without delay.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする